{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:20:38Z","timestamp":1762161638118,"version":"build-2065373602"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.prp.2021.153370","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T01:30:42Z","timestamp":1612834242000},"page":"153370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Prognostic value of Bcl2 and p53 in Hodgkin lymphoma: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"219","author":[{"given":"Antonio","family":"Travaglino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Varricchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Picardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Mascolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"127","key":"10.1016\/j.prp.2021.153370_bib0005","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.prp.2021.153370_bib0010","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.3109\/10428194.2010.525724","article-title":"Comparing adult and pediatric Hodgkin lymphoma in the Surveillance, Epidemiology and End Results Program, 1988\u20132005: an analysis of 21 734 cases","volume":"51","author":"Bazzeh","year":"2010","journal-title":"Leuk. Lymphoma"},{"year":"2020","series-title":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) - Hodgkin Lymphoma","author":"Hoppe","key":"10.1016\/j.prp.2021.153370_bib0015"},{"key":"10.1016\/j.prp.2021.153370_bib0020","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/1097-0142(197507)36:1<252::AID-CNCR2820360128>3.0.CO;2-7","article-title":"Combination chemotherapy of Hodgkin\u2019s disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP","volume":"36","author":"Bonadonna","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2021.153370_bib0025","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1000067","article-title":"Reduced treatment intensity in patients with early-stage Hodgkin\u2019s lymphoma","volume":"363","author":"Engert","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2021.153370_bib0030","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u2019s disease: cotswolds meeting","volume":"7","author":"Lister","year":"1989","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2021.153370_bib0035","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1200\/JCO.2010.29.8018","article-title":"Intensified chemotherapy and dose reduced involved-field radiotherapy in patients with early unfavourable Hodgkin\u2019s lymphoma: final analysis of the German Hodgkin Study Group HD11 trial","volume":"28","author":"Eich","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2021.153370_bib0040","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1182\/blood-2014-07-537480","article-title":"Risk assessment in the management of newly diagnosed classical Hodgkin lymphoma","volume":"125","author":"Connors","year":"2015","journal-title":"Blood"},{"issue":"November (5-6)","key":"10.1016\/j.prp.2021.153370_bib0045","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3109\/10428190009113386","article-title":"Epstein-Barr virus-latent membrane protein 1 expression has a favorable influence in the outcome of patients with Hodgkin\u2019s Disease treated with chemotherapy","volume":"39","author":"Montalban","year":"2000","journal-title":"Leuk. Lymphoma"},{"issue":"March (3)","key":"10.1016\/j.prp.2021.153370_bib0050","first-page":"1150","article-title":"Prognostic factors in Hodgkin\u2019s disease: multivariate analysis of 327 patients from a single institution","volume":"6","author":"Smolewski","year":"2000","journal-title":"Clin. Cancer Res."},{"issue":"December 1 (12)","key":"10.1016\/j.prp.2021.153370_bib0055","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1182\/blood.V100.12.3935","article-title":"BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens","volume":"100","author":"Rassidakis","year":"2002","journal-title":"Blood"},{"issue":"January 15 (2)","key":"10.1016\/j.prp.2021.153370_bib0060","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1182\/blood-2002-04-1128","article-title":"Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays","volume":"101","author":"Garc\u00eda","year":"2003","journal-title":"Blood"},{"issue":"May 1 (9)","key":"10.1016\/j.prp.2021.153370_bib0065","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1200\/JCO.2004.06.105","article-title":"Influence of biologic markers on the outcome of Hodgkin\u2019s lymphoma: a study by the Spanish Hodgkin\u2019s Lymphoma Study Group","volume":"22","author":"Montalb\u00e1n","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"September (9)","key":"10.1016\/j.prp.2021.153370_bib0070","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1080\/10428190500126034","article-title":"The prognostic value of the expression of Bcl-2, p53 and LMP-1 in patients with Hodgkin\u2019s lymphoma","volume":"46","author":"Spector","year":"2005","journal-title":"Leuk. Lymphoma"},{"issue":"June 1 (16)","key":"10.1016\/j.prp.2021.153370_bib0075","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1200\/JCO.2005.04.358","article-title":"Expression of bcl-2 in classical Hodgkin\u2019s lymphoma: an independent predictor of poor outcome","volume":"23","author":"Sup","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"September (9)","key":"10.1016\/j.prp.2021.153370_bib0080","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/01.mph.0000212955.43350.bb","article-title":"No Influence of bcl-2, p53, and p21waf1 protein expression on the outcome of pediatric Hodgkin lymphomas","volume":"28","author":"Chabay","year":"2006","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2021.153370_bib0085","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/lrb.2007.5305","article-title":"Prognostic significance of cell proliferation and apoptosis-regulating proteins in Epstein-Barr virus positive and negative pediatric Hodgkin lymphoma","volume":"5","author":"Akta\u015f","year":"2007","journal-title":"Lymphat. Res. Biol."},{"issue":"12","key":"10.1016\/j.prp.2021.153370_bib0090","first-page":"733","article-title":"Prognostic significance of Bcl-2, tumor-associated macrophages, and total neoplastic and inflammatory lymph node involvement in advanced stage classical Hodgkin\u2019s lymphoma","volume":"35","author":"Jakovic","year":"2012","journal-title":"Onkologie"},{"issue":"December (6)","key":"10.1016\/j.prp.2021.153370_bib0095","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1309\/NB3947K383DJ0LQ2","article-title":"The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T\/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression","volume":"128","author":"Kelley","year":"2007","journal-title":"Am. J. Clin. Pathol."},{"issue":"February (2)","key":"10.1016\/j.prp.2021.153370_bib0100","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/pbc.21204","article-title":"Proliferative index and CD15 expression in pediatric classical Hodgkin lymphoma","volume":"50","author":"Dinand","year":"2008","journal-title":"Pediatr. Blood Cancer"},{"issue":"Novomber (5)","key":"10.1016\/j.prp.2021.153370_bib0105","first-page":"526","article-title":"Low apoptotic index & bak expression in EBV-associated childhood classical Hodgkin lymphoma","volume":"130","author":"Dinand","year":"2009","journal-title":"Indian J. Med. Res."},{"issue":"July 22 (7)","key":"10.1016\/j.prp.2021.153370_bib0110","doi-asserted-by":"crossref","first-page":"e6341","DOI":"10.1371\/journal.pone.0006341","article-title":"Prognostic significance of new immunohistochemical markers in refractory classical Hodgkin lymphoma: a study of 59 cases","volume":"4","author":"Canioni","year":"2009","journal-title":"PLoS One"},{"issue":"March 5","key":"10.1016\/j.prp.2021.153370_bib0115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1746-1596-5-19","article-title":"Expression and prognostic significance of Cox-2 and p-53 in Hodgkin lymphomas: a retrospective study","volume":"26","author":"Barisik","year":"2010","journal-title":"Diagn. Pathol."},{"issue":"January (1)","key":"10.1016\/j.prp.2021.153370_bib0120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/PAI.0b013e3181b473b7","article-title":"High dose chemoradiotherapy and ASCT may overcome the prognostic importance of biologic markers in relapsed\/refractory Hodgkin lymphoma","volume":"18","author":"Persky","year":"2010","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"issue":"September (9)","key":"10.1016\/j.prp.2021.153370_bib0125","first-page":"1686","article-title":"Late relapses in Hodgkin lymphoma: a clinical and immunohistochemistry study","volume":"51","author":"Provencio","year":"2010","journal-title":"Leuk. Lymphoma"},{"issue":"June (7)","key":"10.1016\/j.prp.2021.153370_bib0130","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1365-2559.2011.03803.x","article-title":"Expression of heat shock proteins in classical Hodgkin lymphoma: correlation with apoptotic pathways and prognostic significance","volume":"58","author":"Sant\u00f3n","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2021.153370_bib0135","doi-asserted-by":"crossref","first-page":"322","DOI":"10.7150\/jca.4716","article-title":"Primary refractory and relapsed classical hodgkin lymphoma - significance of differential CD15 expression in Hodgkin-Reed-Sternberg cells","volume":"3","author":"Benharroch","year":"2012","journal-title":"J. Cancer"},{"issue":"August (8)","key":"10.1016\/j.prp.2021.153370_bib0140","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/PAS.0b013e31828b6ad3","article-title":"Prognostic significance of COX-2 expression and correlation with Bcl-2 and VEGF expression, microvessel density, and clinical variables in classical Hodgkin lymphoma","volume":"37","author":"Koh","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"issue":"October (10)","key":"10.1016\/j.prp.2021.153370_bib0145","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/modpathol.2014.38","article-title":"LGALS3 as a prognostic factor for classical Hodgkin\u2019s lymphoma","volume":"27","author":"Koh","year":"2014","journal-title":"Mod. Pathol."},{"issue":"November (11)","key":"10.1016\/j.prp.2021.153370_bib0150","first-page":"926","article-title":"[Expression and prognostic value of COX- 2, p16(INK4A) and p53 in patients with classical Hodgkin lymphoma]","volume":"36","author":"Shi","year":"2015","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"May (5)","key":"10.1016\/j.prp.2021.153370_bib0155","article-title":"Histology of pediatric classic Hodgkin lymphoma: from diagnosis to prognostic stratification","volume":"67","author":"Pizzi","year":"2020","journal-title":"Pediatr. Blood Cancer"},{"issue":"April (4)","key":"10.1016\/j.prp.2021.153370_bib0160","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/apm.12938","article-title":"PTEN immunohistochemistry in endometrial hyperplasia: which are the optimal criteria for the diagnosis of precancer?","volume":"127","author":"Travaglino","year":"2019","journal-title":"APMIS"},{"issue":"June (6)","key":"10.1016\/j.prp.2021.153370_bib0165","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/apm.12945","article-title":"Complexity of glandular architecture should be reconsidered in the classification and management of endometrial hyperplasia","volume":"127","author":"Travaglino","year":"2019","journal-title":"APMIS"},{"issue":"4","key":"10.1016\/j.prp.2021.153370_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","author":"Moher","year":"2015","journal-title":"Syst. Rev."},{"issue":"8","key":"10.1016\/j.prp.2021.153370_bib0175","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann. Intern. Med."},{"issue":"October (4)","key":"10.1016\/j.prp.2021.153370_bib0180","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s12253-020-00848-6","article-title":"Involvement of Helicobacter pylori in ocular adnexa lymphoma","volume":"26","author":"Travaglino","year":"2020","journal-title":"Pathol. Oncol. Res."},{"issue":"4","key":"10.1016\/j.prp.2021.153370_bib0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.152864","article-title":"Hepatitis C virus in MALT-lymphoma of the ocular adnexa","volume":"216","author":"Travaglino","year":"2020","journal-title":"Pathol. Res. Pract."},{"issue":"6","key":"10.1016\/j.prp.2021.153370_bib0190","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/ajcp\/aqaa005","article-title":"Sj\u00f6gren syndrome in primary salivary gland lymphoma","volume":"153","author":"Travaglino","year":"2020","journal-title":"Am. J. Clin. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2021.153370_bib0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.152819","article-title":"Clinical features associated with high pathological grade in primary thyroid lymphoma","volume":"216","author":"Travaglino","year":"2020","journal-title":"Pathol. Res. Pract."},{"issue":"4","key":"10.1016\/j.prp.2021.153370_bib0200","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/ajcp\/aqz181","article-title":"Prevalence of Chlamydia psittaci, Chlamydia pneumoniae, and Chlamydia trachomatis determined by molecular testing in ocular adnexa lymphoma specimens","volume":"153","author":"Travaglino","year":"2020","journal-title":"Am. J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.prp.2021.153370_bib0205","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ajcp\/aqz145","article-title":"Hashimoto thyroiditis in primary thyroid non-hodgkin lymphoma","volume":"153","author":"Travaglino","year":"2020","journal-title":"Am. J. Clin. Pathol."},{"issue":"November (11)","key":"10.1016\/j.prp.2021.153370_bib0210","article-title":"HIV prevalence in primary central nervous system lymphoma: a systematic review and meta-analysis","volume":"216","author":"Franca","year":"2020","journal-title":"Pathol. Res. Pract."},{"issue":"December (12)","key":"10.1016\/j.prp.2021.153370_bib0215","first-page":"1379","article-title":"Borrelia burgdorferi in primary cutaneous lymphomas: a systematic review and meta-analysis","volume":"18","author":"Travaglino","year":"2020","journal-title":"J. Dermatol. Ges."},{"issue":"1","key":"10.1016\/j.prp.2021.153370_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408360500295626","article-title":"BCL2 family of apoptosis-related genes: functions and clinical implications in cancer","volume":"43","author":"Thomadaki","year":"2006","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"4","key":"10.1016\/j.prp.2021.153370_bib0225","first-page":"363","article-title":"Immunohistochemical tumour markers in endometrial carcinoma","volume":"26","author":"Ioachin","year":"2005","journal-title":"Eur. J. Gynaecol. Oncol."},{"issue":"November 862","key":"10.1016\/j.prp.2021.153370_bib0230","article-title":"Current overview on the clinical update of Bcl-2 anti-apoptotic inhibitors for cancer therapy","volume":"5","author":"Suvarna","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"December (12)","key":"10.1016\/j.prp.2021.153370_bib0235","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/aogs.13452","article-title":"Loss of B-cell lymphoma 2 immunohistochemical expression in endometrial hyperplasia: a specific marker of precancer and novel indication for treatment: a systematic review and meta-analysis","volume":"97","author":"Travaglino","year":"2018","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"January (1)","key":"10.1016\/j.prp.2021.153370_bib0240","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3892\/or.2016.5274","article-title":"Potential role of BCL2 in the recurrence of uterine smooth muscle tumors of uncertain malignant potential","volume":"37","author":"Conconi","year":"2017","journal-title":"Oncol. Rep."},{"issue":"May 1 (2)","key":"10.1016\/j.prp.2021.153370_bib0245","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ygyno.2011.01.022","article-title":"Uterine leiomyosarcomas: tumor size, mitotic index, and biomarkers Ki67, and Bcl-2 identify two groups with different prognosis","volume":"121","author":"D\u2019Angelo","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2021.153370_bib0250","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/gut.43.3.383","article-title":"Loss of Bcl-2 expression correlates with tumour recurrence in colorectal cancer","volume":"43","author":"Ilyas","year":"1998","journal-title":"Gut"},{"issue":"December (6)","key":"10.1016\/j.prp.2021.153370_bib0255","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/cpt.1956","article-title":"Mukhopadhyay P. Relationship between progression-free survival, objective response rate, and overall survival in clinical trials of PD-1\/PD-L1 immune checkpoint blockade: a meta-analysis","volume":"108","author":"Ye","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"issue":"December 7","key":"10.1016\/j.prp.2021.153370_bib0260","first-page":"57","article-title":"Uncovering the role of p53 splice variants in human malignancy: a clinical perspective","volume":"19","author":"Surget","year":"2013","journal-title":"Onco. Ther."},{"issue":"August (8)","key":"10.1016\/j.prp.2021.153370_bib0265","article-title":"Diagnostic accuracy of p53 immunohistochemistry as surrogate of TP53 sequencing in endometrial cancer","volume":"216","author":"Raffone","year":"2020","journal-title":"Pathol. Res. Pract."},{"issue":"January Suppl 1","key":"10.1016\/j.prp.2021.153370_bib0270","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1097\/PGP.0000000000000488","article-title":"Interpretation of P53 immunohistochemistry in endometrial carcinomas: toward increased reproducibility","volume":"38","author":"K\u00f6bel","year":"2019","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"May 14 (9)","key":"10.1016\/j.prp.2021.153370_bib0275","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1182\/bloodadvances.2019000123","article-title":"Brentuximab vedotin followed by bendamustine supercharge for refractory or relapsed Hodgkin lymphoma","volume":"3","author":"Picardi","year":"2019","journal-title":"Blood Adv."},{"issue":"June","key":"10.1016\/j.prp.2021.153370_bib0280","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejca.2020.03.008","article-title":"2-deoxy-2[F-18] fluoro-D-glucose positron emission tomography Deauville scale and core-needle biopsy to determine successful management after six doxorubicin, bleomycin, vinblastine and dacarbazine cycles in advanced-stage Hodgkin lymphoma","volume":"132","author":"Picardi","year":"2020","journal-title":"Eur. J. Cancer"},{"issue":"January","key":"10.1016\/j.prp.2021.153370_bib0285","article-title":"Apoptotic regulator BCL-2 blockade as a potential therapy in classical Hodgkin Lymphoma","volume":"6","author":"Gamboa-Cede\u00f1o","year":"2021","journal-title":"Life Sci."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033821000315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033821000315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:46:14Z","timestamp":1759733174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033821000315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":57,"alternative-id":["S0344033821000315"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2021.153370","relation":{},"ISSN":["0344-0338"],"issn-type":[{"type":"print","value":"0344-0338"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of Bcl2 and p53 in Hodgkin lymphoma: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2021.153370","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153370"}}